Skip to main content

Table 2 Clinical and medication characteristics of study participants in the Amhara region public hospitals (2010–2016)

From: Predictors of CD4 count changes over time among children who initiated highly active antiretroviral therapy in Ethiopia

Variable

Category

Number

%

Regimen type

d4T + 3TC + NVP

327

34.3

d4T + 3TC + EFV

76

8.0

AZT + 3TC + NVP

333

34.9

AZT + 3TC + EFV

160

16.8

Others

55

5.8

Functional status

Working

323

33.9

Ambulatory

462

48.4

Bedridden

166

17.5

BWHO stage

Stage I

286

29.9

Stage II

309

32.4

Stage III

287

30.1

Stage IV

69

7.2

Disclosure

Yes

720

75.7

No

231

24.3

Opportunistic infection

Yes

691

72.7

No

260

27.3

MARV status

Yes

909

95.6

No

42

4.4

Medication adherence

Poor

291

38.04

Fair

117

15.29

Good

357

46.67

  1. BWHO baseline WHO stage, MARV mothers’ antiretroviral